CLINICAL_TRIALS
trial_result
· 2019-03-13
Clinical Trial Update: Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD [Phase 2]
Summary
Phase 2 clinical trial update on novel brain-targeted strategies for pediatric obsessive compulsive disorder, with results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Obsessive Compulsive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2019-03-13